Thymosin β4 in rheumatoid arthritis: Friend or foe.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biomedical Reports

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/br.2017.952PMID 28808568PMCID PMC5543423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells

  2016cited by this paper
• Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor

  2016cited by this paper
• Redox signaling in rheumatoid arthritis and the preventive role of polyphenols.

  2016cited by this paper
• Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis

  2016cited by this paper
• Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

  2016cited by this paper
• Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis.

  2016cited by this paper
• Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants.

  2016cited by this paper
• [Rheumatoid arthritis and cytokines].

  2016cited by this paper
• Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis

  2016cited by this paper
• Effect of Thymosin beta4 on the Differentiation and Mineralization of MC3T3-E1 Cell on a Titanium Surface.

  2016cited by this paper
• Thymosin &bgr;4 inhibits microglia activation through microRNA 146a in neonatal rats following hypoxia injury

  2015cited by this paper
• Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation.

  2015cited by this paper
• One year in review: the pathogenesis of rheumatoid arthritis.

  2015cited by this paper
• A paradigm shift in rheumatoid arthritis over the past decade.

  2014cited by this paper
• Increased thymosin β4 levels in the serum and SF of knee osteoarthritis patients correlate with disease severity.

  2013cited by this paper
• How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy

  2013cited by this paper
• Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine

  2012cited by this paper
• Plant Innate Immunity Induced by Flagellin Suppresses the Hypersensitive Response in Non-Host Plants Elicited by Pseudomonas syringae pv. averrhoi

  2012cited by this paper
• Thymosin Beta 4 Protects Cardiomyocytes from Oxidative Stress by Targeting Anti-Oxidative Enzymes and Anti-Apoptotic Genes

  2012cited by this paper
• Thymosin β4: a potential molecular target for tumor therapy.

  2012cited by this paper
• Promoting effects of thymosin β4 on granulation tissue and new bone formation after tooth extraction in rats.

  2012cited by this paper
• Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy

  2012cited by this paper
• Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints

  2011cited by this paper
• Thymosin &bgr;4 Expression in Human Tissues and in Tumors Using Tissue Microarrays

  2011cited by this paper
• The pathogenesis of rheumatoid arthritis.

  2011cited by this paper
• Citrullinated peptide and its relevance to rheumatoid arthritis: an update

  2010cited by this paper
• Thymosin-β4 Attenuates Ethanol-induced Neurotoxicity in Cultured Cerebral Cortical Astrocytes by Inhibiting Apoptosis

  2009cited by this paper
• Exogenous thymosin β4 prevents apoptosis in human intervertebral annulus cells in vitro

  2009cited by this paper
• Study of the human plasma proteome of rheumatoid arthritis.

  2009cited by this paper
• Thymosin beta4 is cytoprotective in human gingival fibroblasts.

  2008cited by this paper
• Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage

  2008cited by this paper
• Thymosin beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation

  2008cited by this paper
• Molecular aspects of rheumatoid arthritis: role of environmental factors

  2008cited by this paper
• Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

  2007cited by this paper
• Cytokines in the pathogenesis of rheumatoid arthritis

  2007cited by this paper
• Thymosin beta4 and angiogenesis: modes of action and therapeutic potential.

  2007cited by this paper
• Matrix metalloproteinase activity is necessary for thymosin beta 4 promotion of epithelial cell migration

  2007cited by this paper
• Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent

  2007cited by this paper
• Thymosin β4 and angiogenesis: modes of action and therapeutic potential

  2007cited by this paper
• Thymosin β4 promotes matrix metalloproteinase expression during wound repair

  2006cited by this paper
• Thymosin beta4 induces a conformational change in actin monomers.

  2006cited by this paper
• Thymosin β4 Induces a Conformational Change in Actin Monomers

  2006cited by this paper
• Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.

  2004cited by this paper
• Nuclear localisation of the G-actin sequestering peptide thymosin β4

  2004cited by this paper
• Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock.

  2003cited by this paper
• The actin binding site on thymosin beta4 promotes angiogenesis.

  2003cited by this paper
• Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs.

  1999cited by this paper
• Thymosin β4 Accelerates Wound Healing

  1999cited by this paper
• Thymosin beta4 accelerates wound healing.

  1999cited by this paper
• Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.

  1992cited by this paper
• Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease.

  1988cited by this paper
• Biosynthesis rates and content of thymosin beta 4 in cell lines.

  1985cited by this paper
• Biosynthesis rates and content of thymosin β4 in cell lines

  1985cited by this paper
• Production and characterization of antibodies to thymosin beta 4.

  1983cited by this paper
• Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues.

  1982cited by this paper
• Thymosin stimulates secretion of luteinizing hormone-releasing factor.

  1981cited by this paper
• Predictors of Response to Anti-tnf-therapy among Patients with Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register

  year unknowncited by this paper

• Proteomic Insight into Susac Syndrome Utilizing Tear Fluid—Case Study

  2025cites this paper
• Small Spleen Peptides (SSPs) Shape Dendritic Cell Differentiation through Modulation of Extracellular ATP Synthesis Profile

  2024cites this paper
• Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights

  2024cites this paper
• The anti-inflammatory and tolerogenic potential of small spleen peptides

  2024cites this paper
• N-acetyl-seryl-aspartyl-lysyl-proline: A new potential serum biomarker of rheumatoid arthritis

  2021cites this paper
• Jinwujiangu Capsule Treats Fibroblast-Like Synoviocytes of Rheumatoid Arthritis by Inhibiting Pyroptosis via the NLRP3/CAPSES/GSDMD Pathway

  2021cites this paper